Safety and Efficacy of an Oncolytic Viral Strategy Using Bortezomib With ICE/R in Relapsed/Refractory HIV-positive Lymphomas
Blood advances - United States
doi 10.1182/bloodadvances.2018022095
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 20, 2018
Authors
Publisher
American Society of Hematology